.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Queensland Health
Julphar
Argus Health
Deloitte
Chinese Patent Office
Cipla
Covington
Johnson and Johnson
Chubb
Farmers Insurance

Generated: June 25, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 090480

« Back to Dashboard
NDA 090480 describes MUPIROCIN, which is a drug marketed by Perrigo New York, Taro, Glenmark Pharms, Teva, Glenmark Pharms Inc, and Fougera Pharms, and is included in six NDAs. It is available from twenty-five suppliers. Additional details are available on the MUPIROCIN profile page.

The generic ingredient in MUPIROCIN is mupirocin calcium. There are twelve drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the mupirocin calcium profile page.

Summary for NDA: 090480

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Therapeutic Class:Antibacterials
Formulation / Manufacturing:see details

Pharmacology for NDA: 090480

Mechanism of ActionRNA Synthetase Inhibitors

Suppliers and Packaging for NDA: 090480

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
MUPIROCIN
mupirocin
OINTMENT;TOPICAL 090480 ANDA DirectRX 61919-407 61919-407-22 22 g in 1 TUBE (61919-407-22)
MUPIROCIN
mupirocin
OINTMENT;TOPICAL 090480 ANDA Proficient Rx LP 63187-015 63187-015-22 22 g in 1 TUBE (63187-015-22)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:OINTMENT;TOPICALStrength2%
Approval Date:Jun 8, 2011TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Boehringer Ingelheim
Mallinckrodt
UBS
Medtronic
Daiichi Sankyo
Farmers Insurance
Federal Trade Commission
Harvard Business School
AstraZeneca
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot